Apoptosis-inducing agents: a patent review (2010 – 2013)

Bibliography

• Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012;19:107-20
   PubMed Web of Science ®Google Scholar
• Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001;2:589-98
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57
   PubMed Web of Science ®Google Scholar
• Meier P, Finch A, Evan G. Apoptosis in development. Nature 2000;407:796-801
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 2002;109:97-107
   PubMed Web of Science ®Google Scholar
• Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov 2002;1:111-21
   PubMed Web of Science ®Google Scholar
• Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6
   PubMed Web of Science ®Google Scholar
• Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003;2:8543-67
   Google Scholar
• Gastman BR. Apoptosis and its clinical impact. Head Neck 2001;23:409-25
   PubMed Web of Science ®Google Scholar
• Chipuk JE, Green DR. How do Bcl-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 2008;18:157-64
   PubMed Web of Science ®Google Scholar
• Thornberry NA. Caspases: key mediators of apoptosis. Chem Biol 1998;5:R97103
   Google Scholar
• Available from: http://www.britannica.com/EBchecked/topic/264227/heterocyclic-compound/277878/Five-and-six-membered-rings-with-two-or-more-heteroatoms
   Google Scholar
• Aberra F. Roll of pharmacologically active metabolites in drug discovery and development. Drug Discov Today 2006;11:133-42
   PubMedGoogle Scholar
• Kunzer AR, Elmore SW, Hexamer A, et al. Preparation of heterocyclic apoptosis-inducing agents for treatment of cancer and immune disorders. WO083442; 2010
   Google Scholar
• Wang Z. Preparation of heteroarylmethylenepyrrole derivatives for use as apoptosis inducers. WO053045; 2013
   Google Scholar
• Ham SU. Preparation of 2-aminothiazole derivatives as antitumor agents. KR017196; 2012
   Google Scholar
• Lee YH, Shin SY, Lim YH, et al. Preparation of bis(2-hydroxylbenzylamino)(pyridin-2-yl)methane as apoptosis inducer. KR139392; 2011
   Google Scholar
• Bae IH, Jun MA, Song JY, et al. Preparation of pyrazinone derivatives having apoptosis-inducing activity. WO090316; 2011
   Google Scholar
• Kamal A, Srikanth YVV, Khan MNA, et al. Benzothiazole derivatives as potential anticancer agents and apoptosis inducers and process for the preparation thereof. WO111016; 2012
   Google Scholar
• Hergenrother PJ, Peterson QP, Hsu DC, et al. Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs. WO091382; 2010
   Google Scholar
• Surolia A, Rai A, Panda D. Rhodanine compounds as tubulin binding anti-cancer agent and their application in treating cancers. IN2011DE01167; 2012
   Google Scholar
• Ikeda T, Ono M, Ueno S, et al. Preparation of 2-azolylpyrrole compounds as tubulin polymerization inhibitors and antitumor agents. WO111831; 2013
   Google Scholar
• Hitchcock M, Mengel A, Richter A, et al. Preparation of substituted benzylpyrazoles. WO092512; 2013
   Google Scholar
• Lim YH, Lee YH, Ko DS, et al. Preparation of trimethoxyphenyl-4,5-dihydro-1H-pyrazol-3-yl-naphthalen-2-ol derivatives having apoptosis-inducing activity. KR049011; 2012
   Google Scholar
• Li N, Cao X, Qiu J. {3-[2-(2-Hydroxy-5-nitrophenyl)-5-phenyl-1-H-imidazole-4-yl]phenyl} phenyl ketone as human PEBP4-targeting antitumor compound, its formulation and application. CN101810608; 2010
   Google Scholar
• Kovach JS, Zhuang Z, Lu J. Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase. WO014141; 2010
   Google Scholar
• Wang L, Doherty G, Wang X, et al. Preparation of substituted benzothiazoles as apoptosis-inducing agents for the treatment of cancer, immune and autoimmune diseases. WO055895; 2013
   Google Scholar
• Weinberg JB, Friedman DR, Cianciolo GJ, et al. Method of inducing apoptosis/cell death in leukemia cell using a purine nucleoside analogue. US0319360; 2011
   Google Scholar
• Le DT, Casara P, Starck JB, et al. New indolizine derivatives, their preparation as pro-apoptotic and antitumor agents and their pharmaceutical compositions containing them. FR2986002; 2013
   Google Scholar
• Brown D, Husband AJ, Mor G, et al. Methods using chroman compounds for inducing programmed cell death. CA2641541; 2010
   Google Scholar
• Husband AJ, Brown D, Morn G, et al. Methods using chroman compounds for inducing programmed cell death. WO045674; 2010
   Google Scholar
• Govindan SV, Goldenberg DM. Camptothecin conjugates with anti-CD22 antibodies for the treatment of B cell diseases. US0305631; 2011
   Google Scholar
• Lu X, Zheng Z, Ma Y, et al. Xanthone compounds with antitumor activity, preparation and application thereof. CN101723952; 2010
   Google Scholar
• Anderson MB, Willardsen JA, Weiner WS, et al. Preparation of 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis. US0069383; 2010
   Google Scholar
• Yanagawa H, Hayakawa I, Shiheido H, et al. Antitumor agent containing thalidomide derivative as active ingredient. WO061862; 2010
   Google Scholar
• Cai SX, Vaillancourt MT, Claassen G. Compounds and methods of inducing apoptosis via interaction with chaperonin CCT, use for the treatment of diseases responsive to induction of the caspase cascade, and screening methods. WO008558; 2010
   Google Scholar
• Brugge J, Hung MC, Mills GB. A new mutational AKTivation in the PI3K pathway. Cancer Cell 2007;12:104-7
   PubMed Web of Science ®Google Scholar
• Vennemann MB, Thomas MT, Hoelder SB, et al. Preparation of fused pyrimidines as Akt inhibitors. WO091824; 2010
   Google Scholar
• Reddy EP, Reddy MVT. Preparation of substituted pyrido[2,3-d]pyrimidin-7(8H)-ones as lk2 kinase inhibitors and anti-tumor agents. WO075616; 2011
   Google Scholar
• Tanuma S, Fujiwara M. Glyoxalase I inhibitors as antitumor agents. JP2011219384; 2011
   Google Scholar
• Zhang S, Gao Z, Cheng X, et al. Application of adenosine in preparing antitumor agent. CN102178689; 2011
   Google Scholar
• Huang HS, Cha TC, Cha TL. Methods for inhibiting cancer cell proliferation and inducing cancer cell apoptosis using anthraquinone derivative, anthra[2,1-c][1,2,5]thiadiazole-6,11-dione (NSC745885). US0122937; 2012
   Google Scholar
• Cotter FE. Preparation of isoquinolines and pyridopyrimidines for inducing cellular apoptosis. WO125343; 2010
   Google Scholar
• Pechan P, Havlicek L. 5,7-Disubstituted 3-isopropylpyrazolo[4,3-d]pyrimidines, and their preparation and use for inhibiting proliferation and inducing apoptosis in mammalian cells, specifically in preventing, inhibiting or treating restenosis. WO139288; 2010
   Google Scholar
• Kaminishi H, Kinjo J, Tsuchihashi R, et al. 3-(Aminocarbonyl)-1-[5-O-[[1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-D-ribofuranos-5-Oyl]phosphonyloxy(oxylato)phosphinyl]-beta-L-ribofuranosyl]pyridinium, its preparation, and axon elongation and neurite outgrowth promoter, antitumor agent, and food containing it. WO004917; 2012
   Google Scholar
• Adra CN, Aldhfyan A. Use of thiazolobenzimidazole compounds for the treatment of tumors and proliferative disorders. WO077295; 2010
   Google Scholar
• Casara P, Le Diguarher T, Durand D, et al. New tricyclic derivatives, their preparation as pro-apoptotic and antitumor agents and their pharmaceutical compositions containing them. WO007248; 2010
   Google Scholar
• Bruncko M, Ding H, Doherty G, et al. Preparation of N-(phenylsulfonyl)benzamides and N-(3-pyridylsulfonyl)benzamides as apoptosis-inducing agents for the treatment of cancer and immune diseases and autoimmune diseases. WO138588; 2010
   Google Scholar
• Bruncko M, Ding H, Doherty GA, et al. Preparation of N-acylsulfonamide Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases. US0298321; 2010
   Google Scholar
• Bruncko M, Dai Y, Ding H, et al. Benzamide-sulfonamide derivatives as apoptosis-inducing agents and their preparation, pharmaceutical compositions and use in the treatment of cancer and immune and autoimmune diseases. US0298323; 2010
   Google Scholar
• Hexamer L, Ding H, Elmore SW, et al. Preparation of cyclic sulfonamide compounds as apoptosis-inducing agents that act by inhibiting Bcl-2 proteins for the treatment of cancer and immune and autoimmune diseases. WO083441; 2010
   Google Scholar
• Lawrence H, Ge Y, Sebti SM, et al. Preparation of 2-amino-1,4-naphthoquinones and N-aryl-aromatic sulfonamides as proteasome inhibitors for selectively inducing apoptosis in cancer cells. WO005534; 2010
   Google Scholar
• Catron ND, Chen S, Gong Y, et al. Preparation of chlorophenyldimethyl cyclohexenylmethylpiperazinylnitrotetrahydropyranylmethylaminophenylsulfonylpyrrolopyridinyloxybenzamide salts and crystalline forms for use as apoptosis-inducing agents. WO071336; 2012
   Google Scholar
• Birtalan E, Hoelig P, Lindley DJ, et al. Melt-extruded solid dispersions containing an apoptosis-inducing agent. US0108590; 2012
   Google Scholar
• Tao ZF, Wang X, Souers AJ, et al. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases. WO150016; 2011
   Google Scholar
• Yeaman MR, Yount NY. Peptides and methods for inducing programmed cell death and their use as antimicrobial, antitumor, antiinflammatory, and anti-proliferative agents. WO103567; 2011
   Google Scholar
• Kim TH. An apoptosis-inducing peptide of Noxa protein and its use in cancer therapy. WO027980; 2011
   Google Scholar
• Bae IH, Jun MA, Song JY, et al. Preparation of imidazopyrazinone peptide derivatives with apoptosis inducing activity on cells. WO090317; 2011
   Google Scholar
• Condon SM, Deng Y, Laporte MG, et al. Preparation of dimeric Smac peptidomimetics for treating proliferative diseases, particularly cancers and autoimmune diseases. US0003877; 2011
   Google Scholar
• Wang S, Sun H. Preparation of diazo bicyclic conformationally constrained Smac peptide mimetics as inhibitors of IAP proteins and inducers of apoptosis. WO050068; 2011
   Google Scholar
• Bae IH, Byun EY, Ju HK, et al. Preparation of quinoline or quinazoline peptide derivatives with apoptosis inducing activity on cells. WO030160; 2012
   Google Scholar
• Schmidt WI, Messmer D. Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides. WO114539; 2010
   Google Scholar
• Park GS, Cha Y. Pharmaceutical composition comprising Tcea3 protein and screening method of candidate materials inhibiting metastasis or inducing apoptosis of cancer cells using the same. KR122925; 2011
   Google Scholar
• Zipkin RE, Adams JK, Spiegel S, et al. Novel sphingosine kinase type 1 inhibitors, compositions and processes for using same. US0035959; 2010
   Google Scholar
• Salsbury FR, Scarpinato KD, King SB. Chemotherapeutic for inducing an MSH2-dependent apoptotic pathway. US0239522; 2010
   Google Scholar
• Ahn JS, Kim BY, He L, et al. Acylamides inducing apoptosis of cancer cells. WO064745; 2010
   Google Scholar
• Gao XM, Yu TL, Kathy Q, et al. Hela-cell apoptosis inducing natural compounds from Garcinia paucinervis and therapeutic uses thereof. US0301236; 2011
   Google Scholar
• Wu YC, Lu MC, Chang FR, et al. Method of preparation of ethanol extract of Antrodia camphorata for inducing apoptosis. US0210869; 2010
   Google Scholar
• Moreno O. Isoflavonoid compositions and methods for the treatment of cancer. WO061413; 2012
   Google Scholar
• Kawai J, Simizu T. Apoptosis inducer containing ergosterol derivative for treatment of lung, tongue, or cervical cancer, and production thereof from agaricus. WO073085; 2013
   Google Scholar
• Young MP, Mckeown P. Dexanabinol and derivatives thereof for inducing cancer cell apoptosis. WO030106; 2011
   Google Scholar
• Kachlany SC. Combination therapy with leukotoxin to treat cancer. WO125942; 2012
   Google Scholar
• Yu DS, Liying FB, Wang Y. Flavonoid glycoside of Camellia chrysantha, and preparation method and application thereof. CN102617672; 2012
   Google Scholar
• Zhang L, Yu H, Bao J, et al. Application of curcumin in preparing antitumor agent for treating thyroid cancer. CN102319234; 2012
   Google Scholar
• Zhang G, Wang Z, Wu J. Application of houttuynoid b in the medicine for treating leukemia. CN102861060; 2013
   Google Scholar
• Fu J, Yang L, Qiu Y, et al. Application of celastrol in antitumor agent for treating glioma and preparation method thereof. CN102349917; 2012
   Google Scholar
• Zhang Z, Xie F. (E, E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile and its derivatives as Bcl-2 family protein inhibitors for inducing cancer cell apoptosis. CN102212613; 2011
   Google Scholar
• Sarkar FH, Mohammad RM. Thymoquinone analogs for the treatment of pancreatic cancer. WO126544; 2011
   Google Scholar
• Lim YH, Lee YH, Ko DS, et al. Preparation of chalcone derivative having apoptosis-inducing activity. KR047503; 2012
   Google Scholar
• Ukiya M. Antitumor steviol derivatives, and pharmaceuticals and apoptosis inducers containing the derivatives. JP074065; 2011
   Google Scholar
• Sebti SM, Hamilton AD, Sill K, et al. Compounds and methods for inducing apoptosis in cancer cells using a bh3 alpha-helical mimetic. WO097133; 2012
   Google Scholar
• Kamal A, Suresh P, Kumar BA, et al. Synthesis of new 4-beta-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof. US0225672; 2013
   Google Scholar
• Kamal A, Suresh P, Kumar BA, et al. Biological evaluation of 4-aza-2,3-didehydropodophyllotoxin analogues possessing potent antitumour activity. US522219; 2013
   Google Scholar
• Kamal A, Shetti RVCRNC, Reddy KS, et al. Carbazole linked pyrrolo[2,1-c][1,4]benzodiazefine hybrids as potential anticancer agents and process for the preparation thereof. US0131336; 2013
   Google Scholar
• Kamal A, Shetti RVCRNC, Ramaiah MJ, et al. Carbazole–pyrrolo[2,1-c][1,4]benzodiazepine conjugates: design, synthesis, and biological evaluation. Med Chem Commun 2011;2:780-8
   Google Scholar
• Kamal A, Bharathi EV, Ramaiah MJ, et al. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: design, synthesis and biological evaluation as potential anticancer agents. Bioorg Med Chem 2010;18:526-42
   PubMed Web of Science ®Google Scholar
• Kamal A, Bharathi EV, Dudekula D, et al. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) hybrids as potential anticancer agents and process for the preparation thereof. US0095214; 2012
   Google Scholar
• Kamal A, Bharathi EV, Reddy JS, et al. Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids a potential anticancer agents and process for the preparation thereof. WO058417A; 2010
   Google Scholar
• Kamal A, Bharathi EV, Reddy JS, et al. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2, 3-dihydroquinazolinone hybrids as anticancer agents. Eur J Med Chem 2011;46:691-703
   PubMed Web of Science ®Google Scholar
• Kamal A, Ramakrishna G, Raju P, et al. Design, synthesis and biological evaluation of imidazo[1,5-a]pyridine–PBD conjugates as potential DNA-directed alkylating agents. Med Chem Commun 2013;4:697-703
   Google Scholar
• Kamal A, Ramakrishna G, Raju P, et al. Pyrrolo[2,1-c][1,4] benzodiazepine linked imidazo[1,5-a]pyridine conjugates as potential antitumour agents and process for the preparation thereof. US0253034; 2012
   Google Scholar
• Kamal A, Reddy MA, Suresh P, et al. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents. Bioorg Med Chem 2012;20:3480-92
   PubMed Web of Science ®Google Scholar
• Kamal A, Reddy MA, Suresh P, et al. Amidobenzothiazole analogues useful as potential anticancer agents and process for the preparation thereof. WO104857A1; 2012
   Google Scholar
• Kamal A, Viswanath A, Murty JNSC, et al. Diaryl ether linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof. WO110840; 2012
   Google Scholar
• Gesguiere A, Mathew M, Hu Z. Cancer therapy via selective uptake of specialized polymer/fullerene nanoparticles in cancer cells to induce apoptosis. US0129664; 2013
   Google Scholar
• Biris A, Mahmood M. Compositions comprising nanoparticles and apoptotic agents and methods of use as cancer chemotherapeutics. WO129797; 2010
   Google Scholar
• Naren M, Chen Z, Liu P, et al. Drug composition for inducing mitochondria apoptosis of multiple myeloma cells. CN103099816; 2013
   Google Scholar
• Blander JM, Torchinsky M. Oral or mucosal vaccines comprising microbe-infected apoptotic cell expressing exogenous antigen for inducing TH17 helper cell response against cancer, autoimmune and TH17-associated diseases. WO068680; 2010
   Google Scholar
• Nashimoto M. Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells. WO022092; 2013
   Google Scholar
• Masuko T, Tanba S, Shindo T, et al. Preparation of antibodies specific for LAT1 neutral amino acid transporter and their application as anticancer agents. JP024537; 2011
   Google Scholar
• Foo HL. Tumor cytotoxic agent and methods thereof using probiotic lactic acid bacteria that produce metabolites. WO074351; 2012
   Google Scholar